当前位置:首页 - 行情中心 - 华北制药(600812) - 财务分析 - 现金流量表

华北制药

(600812)

  

流通市值:100.88亿  总市值:100.88亿
流通股本:17.16亿   总股本:17.16亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金5,427,084,311.733,396,883,405.311,543,655,921.957,556,833,074.36
  收到的税费返还124,236,162.881,119,091.2555,507,842.04105,991,573.5
  收到其他与经营活动有关的现金89,955,535.2967,922,075.1335,355,557.01198,454,535.84
  经营活动现金流入小计5,641,276,009.823,545,924,571.691,634,519,3217,861,279,183.7
  购买商品、接受劳务支付的现金2,616,723,420.81,463,857,685668,605,567.423,294,331,239.88
  支付给职工以及为职工支付的现金960,271,911.27643,990,753.35330,586,738.611,358,374,747.08
  支付的各项税费359,758,331.02271,039,830.5197,446,478.87495,020,001.28
  支付其他与经营活动有关的现金1,043,076,468.39675,538,245.92374,566,716.711,483,987,795.73
  经营活动现金流出小计4,979,830,131.483,054,426,514.781,471,205,501.616,631,713,783.97
  经营活动产生的现金流量净额661,445,878.34491,498,056.91163,313,819.391,229,565,399.73
二、投资活动产生的现金流量:
  取得投资收益收到的现金60,293,032.860,000,00060,000,000710,914.98
  处置固定资产、无形资产和其他长期资产收回的现金净额303,2008,2006,9001,270,171
  收到的其他与投资活动有关的现金---510,004,532.06
  投资活动现金流入小计60,596,232.860,008,20060,006,900511,985,618.04
  购建固定资产、无形资产和其他长期资产支付的现金380,002,187.69235,625,353.31120,585,892.86784,219,498.99
  投资支付的现金300,000,000--674,497,814.81
  投资活动现金流出小计680,002,187.69235,625,353.31120,585,892.861,458,717,313.8
  投资活动产生的现金流量净额-619,405,954.89-175,617,153.31-60,578,992.86-946,731,695.76
三、筹资活动产生的现金流量:
  吸收投资收到的现金205,000,0007,000,000-903,000,000
  其中:子公司吸收少数股东投资收到的现金---900,000,000
  取得借款收到的现金5,835,360,0003,490,450,0001,526,700,0009,793,745,000
  收到其他与筹资活动有关的现金1,020,000,0001,020,000,000449,650,0001,004,700,416.67
  筹资活动现金流入小计7,060,360,0004,517,450,0001,976,350,00011,701,445,416.67
  偿还债务支付的现金5,713,875,623.13,651,677,225.171,267,968,397.939,622,872,723.13
  分配股利、利润或偿付利息支付的现金391,711,985.74257,176,839.4594,467,339.65492,581,063.47
  其中:子公司支付给少数股东的股利、利润66,830,370.9665,332,037.6323,514,00023,514,000
  支付其他与筹资活动有关的现金1,087,423,793.361,122,652,095.72600,950,493.881,123,254,659.13
  筹资活动现金流出小计7,193,011,402.25,031,506,160.341,963,386,231.4611,238,708,445.73
  筹资活动产生的现金流量净额-132,651,402.2-514,056,160.3412,963,768.54462,736,970.94
四、汇率变动对现金及现金等价物的影响3,040,427.583,877,130.092,527,048.3711,828,701.55
五、现金及现金等价物净增加额-87,571,051.17-194,298,126.65118,225,643.44757,399,376.46
  加:期初现金及现金等价物余额1,262,403,953.021,262,403,953.021,262,403,953.02505,004,576.56
  期末现金及现金等价物余额1,174,832,901.851,068,105,826.371,380,629,596.461,262,403,953.02
补充资料:
  净利润-162,286,856.6-214,966,518.33
  资产减值准备--7,432,452.04-16,374,073.77
  固定资产和投资性房地产折旧-326,705,415.13-635,679,352.84
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-326,705,415.13-635,679,352.84
  无形资产摊销-115,523,593.12-157,305,834.77
  长期待摊费用摊销-6,695,415.43-12,014,267.59
  处置固定资产、无形资产和其他长期资产的损失-9,846.67--444,156.56
  固定资产报废损失---136,209.76
  财务费用-190,640,852.41-458,698,019.11
  投资损失--26,285,765.54--46,164,658.18
  递延所得税---8,779,495.24
  其中:递延所得税资产减少----20,324,237.19
    递延所得税负债增加---29,103,732.43
  存货的减少-201,726,632.27-94,320,345.95
  经营性应收项目的减少--658,708,576.05-377,130,760.26
  经营性应付项目的增加-118,609,973.78--792,321,173.66
  现金的期末余额-1,068,105,826.37-1,262,403,953.02
  减:现金的期初余额-1,262,403,953.02-505,004,576.56
  现金及现金等价物的净增加额--194,298,126.65-757,399,376.46
公告日期2025-10-252025-08-142025-04-242025-03-28
审计意见(境内)标准无保留意见
TOP↑